Catalyst Pharmaceutical
CPRX
CPRX
138 hedge funds and large institutions have $376M invested in Catalyst Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 57 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
32% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 57
75% less call options, than puts
Call options by funds: $634K | Put options by funds: $2.57M
Holders
138
Holding in Top 10
–
Calls
$634K
Puts
$2.57M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$4.5M | |
| 3 | +$3.79M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.74M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.65M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$4.71M | |
| 3 | -$3.54M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.45M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.3M |